0001654954-20-000058.txt : 20200206 0001654954-20-000058.hdr.sgml : 20200206 20200103141433 ACCESSION NUMBER: 0001654954-20-000058 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYMETICS CORP CENTRAL INDEX KEY: 0000927761 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 251741849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: EUROPEAN EXECUTIVE OFFICE STREET 2: 4, ROUTE DE LA CORNICHE CITY: EPALINGES STATE: V8 ZIP: CH-1066 BUSINESS PHONE: 011-41-21-653-45-35 MAIL ADDRESS: STREET 1: EUROPEAN EXECUTIVE OFFICE STREET 2: 4, ROUTE DE LA CORNICHE CITY: EPALINGES STATE: V8 ZIP: CH-1066 FORMER COMPANY: FORMER CONFORMED NAME: ICHOR CORP DATE OF NAME CHANGE: 19970407 FORMER COMPANY: FORMER CONFORMED NAME: PDG REMEDIATION INC DATE OF NAME CHANGE: 19940801 CORRESP 1 filename1.htm Blueprint
 
 
MYMETICS CORPORATION
Route de la Corniche 4
1066 Epalinges, Switzerland
 
January 3, 2020
 
Via Edgar Correspondence
Chris Edwards
Office of Life Sciences
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
 
Re:
Mymetics Corporation
Preliminary Information Statement on Schedule 14C
Filed December 27, 2019
File No. 000-25132
 
Dear Mr. Edwards:
 
We have received your correspondence dated December 31, 2019. We have addressed your comment by reproducing it and providing our response immediately thereafter.
 
 General
 
Please revise your disclosure to describe any current plans, arrangements or understandings relating to the issuance of any of the newly authorized shares that would be available as a result of the proposed increase in authorized shares, including the terms of any current financing plans. If you have no such plans, arrangements or understandings, please revise your disclosure to so state.
 
Response: We have revised our Preliminary Information Statement on Schedule 14C in response to this comment.
 
We are filing on EDGAR for SEC access only a marked version of the Schedule 14C to reflect the changes referenced above in response to the SEC’s comment letter. If you have any further comments or questions regarding our response, please contact our legal counsel, Ernest M. Stern, Culhane Meadows PLLC at (301) 910-2030. If you cannot reach him, please contact the undersigned at ronald.kempers@mymetics.com.
 
Sincerely,
 
/s/ Ronald Kempers
 
Ronald Kempers
 
cc: Ernest M. Stern, Esq. (w/encl.)
 
Encl.